These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12766386)

  • 1. In vitro ultrasound augmented clot dissolution--what is the optimal timing of ultrasound application?
    Shlamovitz GZ; Iakobishvili Z; Matz I; Golovchiner G; Lev E; Siegel RJ; Birnbaum Y
    Cardiovasc Drugs Ther; 2002 Dec; 16(6):521-6. PubMed ID: 12766386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. There is synergism between high-intensity, low-frequency ultrasound and streptokinase but not with eptifibatide, heparin, and aspirin. Differential effects on fresh and aged blood clots. An in vitro study.
    Wyshelesky A; Iakobishvili Z; Matz I; Golovchiner G; Vaturi M; Siegel RJ; Birnbaum Y
    Thromb Res; 2001 Aug; 103(4):337-44. PubMed ID: 11562343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution.
    Birnbaum Y; Atar S; Luo H; Nagai T; Siegel RJ
    Thromb Res; 1999 Dec; 96(6):451-8. PubMed ID: 10632468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of streptokinase and hydroxyethyl starch on in vitro clot disruption by ultrasound.
    Adler Y; Attar D; Vaturi M; Golovchiner G; Iakobishvili Z; Battler A; Siegel RJ; Birnbaum Y
    Cardiovasc Drugs Ther; 2001 Mar; 15(2):119-23. PubMed ID: 11669404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs.
    Atar S; Luo H; Birnbaum Y; Nagai T; Siegel RJ
    J Thromb Thrombolysis; 2001 May; 11(3):223-8. PubMed ID: 11577261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism of aspirin and heparin with a low-frequency non-invasive ultrasound system for augmentation of in-vitro clot lysis.
    Atar S; Neuman Y; Miyamoto T; Chen M; Birnbaum Y; Luo H; Kobal S; Siegel RJ
    J Thromb Thrombolysis; 2003 Jun; 15(3):165-9. PubMed ID: 14739625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.
    Marsh JN; Senpan A; Hu G; Scott MJ; Gaffney PJ; Wickline SA; Lanza GM
    Nanomedicine (Lond); 2007 Aug; 2(4):533-43. PubMed ID: 17716136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On thrombolysis with various fibrinolytic agents. II. In vitro studies on intravitally-formed human blood clots].
    Schmidt HW
    Klin Wochenschr; 1966 Jun; 44(11):621-5. PubMed ID: 5987967
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative immunogenicity and thrombolytic properties toward arterial and venous thrombi of streptokinase and recombinant staphylokinase in baboons.
    Collen D; De Cock F; Stassen JM
    Circulation; 1993 Mar; 87(3):996-1006. PubMed ID: 8443918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro- and antifibrinolytic effects of ultrasound on streptokinase-induced thrombolysis.
    Nilsson AM; Odselius R; Roijer A; Olsson SB
    Ultrasound Med Biol; 1995; 21(6):833-40. PubMed ID: 8571471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonothrombolysis is effective with recombinant tissue-type plasminogen activator, but not with Abciximab. Results from an in vitro study with whole blood clots and platelet-rich clots.
    Eggers J; Ossadnik S; Hütten H; Seidel G
    Thromb Haemost; 2009 Dec; 102(6):1274-7. PubMed ID: 19967161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood clot disruption in vitro using shockwaves delivered by an extracorporeal generator after pre-exposure to lytic agent.
    Goldenstedt C; Birer A; Cathignol D; Lafon C
    Ultrasound Med Biol; 2009 Jun; 35(6):985-90. PubMed ID: 19285784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
    Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
    Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolytic agents: efficacy in relation to evolution time and dose].
    García Frade LJ; Torrado MC; Loren M; Navarro JL
    Rev Clin Esp; 1989 Feb; 184(2):75-9. PubMed ID: 2502822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bleeding model in rabbits demonstrate fresh clot selectivity for a genetically engineered variant of tissue-type plasminogen activator and for streptokinase.
    Wikström K; Mattsson C; Pohl G
    Thromb Res; 1993 May; 70(3):217-24. PubMed ID: 8392227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of diagnostic ultrasound on enzymatic thrombolysis. An in vitro study on blood of normal subjects and patients with coronary artery disease.
    Basta G; Lupi C; Lazzerini G; Chiarelli P; L'Abbate A; Rovai D
    Thromb Haemost; 2004 Jun; 91(6):1078-83. PubMed ID: 15175792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microparticle-containing oncotic solutions augment in-vitro clot disruption by ultrasound.
    Birnbaum Y; Iakobishvili Z; Porter A; Hasdai D; Atar S; Siegel RJ; Battler A
    Thromb Res; 2000 Jun; 98(6):549-57. PubMed ID: 10899354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-energy ultrasound exposure of the streptokinase molecule may enhance but also attenuate its fibrinolytic properties.
    Härdig BM; Persson HW; Olsson SB
    Thromb Res; 2006; 117(6):713-20. PubMed ID: 15993473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on experimentally induced hypercoagulable state in rabbits.
    Izak G; Galewsky K
    Thromb Diath Haemorrh; 1966 Jul; 16(1):228-42. PubMed ID: 5989043
    [No Abstract]   [Full Text] [Related]  

  • 20. Augmentation of low-frequency ultrasound-induced clot disruption by hydroxyethyl starch is dependent on the duration and intensity of ultrasound exposure; an in vitro study.
    Adler Y; Dagan A; Golovchiner G; Iakobishvili Z; Matz I; Lev E; Siegel RJ; Birnbaum Y
    Ultrasound Med Biol; 2003 Mar; 29(3):483-6. PubMed ID: 12706200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.